CARsgen Announced 2023 Annual Results

/PRNewswire/ -- March 27, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the...

Related Keywords

London ,City Of ,United Kingdom ,China ,Huadong ,Guangdong ,Canada ,United States ,Shanghai ,American ,Zonghai Li ,Carsgen Therapeutics Holdings Limited Stock Code ,Moderna Inc ,Huadong Medicine Co Ltd ,Carsgen Therapeutics Holdings ,American Society Of Hematology ,Nasdaq ,Huadong Medicine Hangzhou Co Ltd ,National Medical Products Administration ,Therapeutics Holdings Limited ,Stock Code ,Huadong Medicine ,Chief Executive Officer ,Chief Scientific Officer ,Making Cancer Curable ,Annual Meeting ,Cancer Communication ,Therapeutics Holdings ,Carsgen Therapeutics ,